Click on any of the following titles to search for the document in a new window using Google Scholar.
Some of these references may be difficult to locate using Google Scholar. If you are having trouble finding the correct reference paper, try searching for it on PubMed: http://www.ncbi.nlm.nih.gov/PubMed
Involvement of 5-HT6 receptors in nigro-striatal function in rodents
Anne Bourson, Frank G Boess, Michael Bos, Andrew J Sleight
British Journal of Pharmacology
Volume 125, Issue 7, pages 1562-1566, December 1998
Animal Models of Neurological Disorders
Mary Jeanne Kallman
Drug Discovery and Evaluation: Pharmacological Assays, Pages 1-47, 2015
A new dopaminergic nigro-olfactory projection
Günter U. Höglinger, Daniel Alvarez-Fischer, Oscar Arias-Carrión, Miriam Djufri, Andrea Windolph, Ursula Keber, Andreas Borta, Vincent Ries, Rainer K. W. Schwarting, Dieter Scheller, Wolfgang H. Oertel
Acta Meuropathol, 8 June 2015
Resolvin D2 recovers neural injury by suppressing inflammatory mediators expression in lipopolysaccharide-induced Parkinson's disease rat model
Ying Zhang, Ruoyu Zhang, Song Qiao, Jing Fan
Biochemical and Biophysical Research Communications, 27 March 2015
Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease
Mickael Decressac, Stéphanie Pain, Pierre-Yves Chabeauti, Laura Frangeul, Nathalie Thiriet, Herbert Herzog, Jackie Vergote, Sylvie Chalon, Mohamed Jaber, Afsaneh Gaillard
Neurobiology of Aging
Volume 33, Issue 9, September 2012, Pages 2125-2137
The Cortical and Striatal Gene Expression Profile of 100?Hz Electroacupuncture Treatment in 6-Hydroxydopamine-Induced Parkinson's Disease Model
Li-Rong Huo, Xi-Bin Liang, Bo Li, Jian-Tao Liang, Yi He, Yan-Jun Jia, Jun Jia, Xiao-Li Gong, Fen Yu, and Xiao-Min Wang
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 908439, 14 pages
doi:10.1155/2012/908439
Stronger Dopamine D1 Receptor-Mediated Neurotransmission in Dyskinesia
Daniel Farré, Ana Muñoz, EstefanÃa Moreno, Irene Reyes-Resina, Júlia Canet-Pons, Iria G. Dopeso-Reyes, Alberto J. Rico, Carme LluÃs, Josefa Mallol, Gemma Navarro, Enric I. Canela, Antonio Cortés, José L. Labandeira-GarcÃa, Vicent Casadó, José L. Lanciego, Rafael Franco
Molecular Neurobiology, October 2014
Therapeutic Effects of Fucoidan in 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's disease: Role of NADPH oxidase-1
Fei-Long Zhang, Yi He, Yan Zheng, Wen-Jing Zhang, Qi Wang, Yan-Jun Jia, Hai-Long Song, Hai-Ting An, Hao-Bo Zhang, Yan-Jing Qian, Yu-Long Tong, Lin Dong and Xiao-Min Wang
CNS Neuroscience & Therapeutics
Volume 20, Issue 12, pages 1036-1044, December 2014
Hypoxia Promotes Dopaminergic Differentiation of Mesenchymal Stem Cells and Shows Benefits for Transplantation in a Rat Model of Parkinson’s Disease
Yue Wang, Jian Yang, Haisheng Li, Xuan Wang, Lingling Zhu, Ming Fan, Xiaomin Wang
2013 PLoS ONE 8(1): e54296. doi:10.1371/journal.pone.0054296
Angiotensin type 1 receptor blockage reduces l-dopa-induced dyskinesia in the 6-OHDA model of Parkinson's disease. Involvement of vascular endothelial growth factor and interleukin-1β
Ana Muñoz, Pablo Garrido-Gil, Antonio Dominguez-Meijide, Jose L. Labandeira-Garcia
Experimental Neurology, Available online 23 August 2014
Melatonin's Beneficial Effects on Dopaminergic Neurons in the Rat Model of Parkinson's Disease
Manisha Gautam, Reshu Gupta, Ravinder Kumar Saran, and Bal Krishna
Melatonin: Therapeutic Value and Neuroprotection, Chapter 31, 409-420, Sep 30, 2014
Fucoidan Protects against Lipopolysaccharide-Induced Rat Neuronal Damage and Inhibits the Production of Proinflammatory Mediators in Primary Microglia
Yan-Qiu Cui, Yan-Jun Jia, Ting Zhang, Quan-Bin Zhang, Xiao-Min Wang
CNS Neuroscience & Therapeutics
Volume 18, Issue 10, pages 827-833, October 2012
The effect of piribedil on L-DOPA-induced dyskinesias in a rat model of Parkinson’s disease: differential role of α2 adrenergic mechanisms
Manfred Gerlach, Paul Halley, Peter Riederer, Maarten van den Buuse
Journal of Neural Transmission
January 2013, Volume 120, Issue 1, pp 31-36
Inhibition of glutamate and acetylcholine release in behavioral improvement induced by electroacupuncture in parkinsonian rats
Zuoli Sun, Jun Jia, Xiaoli Gong, Yanjun Jia, Jiahui Deng, Xuan Wang, Xiaomin Wang
Neuroscience Letters
Volume 520, Issue 1, 27 June 2012, Pages 32-37
Functional disconnection of the substantia nigra pars compacta from the pedunculopontine nucleus impairs learning of a conditioned avoidance task
Mariza Bortolanza, Evellyn C. Wietzikoski, Suelen L. Boschen, Patricia A. Dombrowski, Mary Latimer, Duncan A.A. MacLaren, Philip Winn and Claudio Da Cunha
Neurobiology of Learning and Memory
Volume 94, Issue 2, September 2010, Pages 229-239
Flibanserin attenuates L-DOPA-sensitized contraversive circling in the unilaterally 6-hydroxydopamine-lesioned rat model of Parkinson’s disease
Manfred Gerlach, Jürgen Beck, Peter Riederer and Maarten van den Buuse
JOURNAL OF NEURAL TRANSMISSION
DOI: 10.1007/s00702-010-0570-9
CART modulates the effects of levodopa in rat model of Parkinson's disease
Manoj A. Upadhya, Gajanan P. Shelkar, Nishikant K. Subhedar, Dadasaheb M. Kokare
Behavioural Brain Research, Vol. 301, Pages 262-272, 15 March 2016
Transplantation of expanded mesencephalic precursors leads to recovery in parkinsonian rats
Lorenz Studer, Viviane Tabar & Ron D.G. McKay
Nature Neuroscience, Vol. 1, No. 4. August 290-295 (1998).
Parkinson’s Disease Experimental Models: BioSupport Ltd. Advancing Science
Jay S. Charleston, Ph.D
Improving Life. (6-OHDA Model)
Delayed Postischemic Hypothermia Improves Long-Term Behavioral Outcome after Cerebral Hypoxia-Ischemia in Neonatal Rats
BENDICHT PETER WAGNER, JOHANN NEDELCU and ERNST MARTIN
Pediatric Research 51:354-360 (2002)
Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity
FEDERICA DABBENI-SALA, STEFANIA DI SANTO, DAVIDE FRANCESCHINI, STEPHEN D. SKAPER, and PIETRO GIUSTI
FASEB J. 15:164-170.
Sonic hedgehog delivered by an adeno-associated virus protects dopaminergic neurones against 6-OHDA toxicity in the rat
B. Dass
1, M. M. Iravani
1, C. Huang
2, J. Barsoum
2, T. M. Engber
2, A. Galdes
2 and P. Jenner
1
Journal of Neural Transmission; Volume 112, Number 6 June 2005 Pages: 763 - 778
Dual effects of intermittent or continuous L-DOPA administration on gene expression in the globus pallidus and subthalamic nucleus of adult rats with a unilateral 6-OHDA lesion
Kirsten M. Nielsen, Jean-Jacques Soghomonian *
Synapse
Volume 49, Issue 4 , Pages 246 - 260
Published Online: 20 Jun 2003
Influence of Polychlorinated Biphenyls and Turning Preference on Striatal Dopamine Metabolism
Nikolay M. Filipov
A1, A2, David A. Lawrence
A1, Richard F. Seegal
A1
Journal of Toxicology and Environmental Health Part A; Volume 68, Number 3 / February 13 2005
Pages: 167 - 183
Expanded mesencephalic precursors develop into grafts of densely packed dopaminergic neurons that reinnervate the surrounding striatum and induce functional responses in the striatal neurons
J. Rodriguez-Pallares, J.A. Parga, P. Rey, M.J. Guerra, J.L. Labandeira-Garcia *
Synapse Volume 58, Issue 1 , Pages 13 - 22
Electro-acupuncture improves behavior and upregulates GDNF mRNA in MFB transected rats
Liang, Xi-Bin 1; Luo, Yong; Liu, Xian-Yu; Lu, Jun; Li, Feng-Qiao 2; Wang, Qian; Wang, Xiao-Min CA; Han, Ji-Sheng
Neuroreport. 14(8):1177-1181, June 11, 2003
Induction of GAP-43 modulates neuroplasticity in PBSC (CD34+) implanted-Parkinson's model
Woei-Cherng Shyu, Kuo-Wei Li, Hsiao-Fen Peng, Shinn-Zong Lin, Ren-Shyan Liu, Hsiao-Jung Wang, Ching-Yuan Su, Yih-Jing Lee4, Hung L
Journal of Neuroscience Research
Volume 87, Issue 9, pages 2020-2033, July 2009
Dopaminergic Properties and Experimental Anti-Parkinsonian Effects of IPX750 in Rodent Models of Parkinson Disease
Jiang, Chuantao; Wan, Xinhua *; Jankovic, Joseph ; Christian, Samuel T.; Pristupa, Zdenek B. [S]; Niznik, Hyman B. [S]; Sundsmo, John S. ; Le, Weidong *
Clinical Neuropharmacology. 27(2):63-73, March/April 2004
Interaction between the noradrenergic and serotonergic systems in locomotor hyperactivity and striatal expression of Fos induced by amphetamine in rats
A. Muñoz
1, A. Lopez-Real
1, J. L. Labandeira-Garcia
1 and M. J. Guerra
1
Experimental Brain Research, Volume 153, Number 1 / November, 2003 Pages 92-99
Brain-Derived Neurotrophic Factor Augments Rotational Behavior and Nigrostriatal Dopamine Turnover in vivo
CA Altar, CB Boylan, C Jackson, S Hershenson, J Miller, SJ Wiegand, RM Lindsay and C Hyman
Proceedings of the National Academy of Sciences, Vol 89, 11347-11351
Effects of Alpha-2 Adrenoceptor Agonists and Antagonists on Circling Behavior in Rats with Unilateral 6-Hydroxydopamine Lesions of the Nigrostriatal Pathway
Philippe Chopin, Francis C. Colpaert and Marc Marien
Pharmacology and Experimental Therapeutics, Vol. 288, Issue 2, 798-804, February 1999
Distinct efficacy of pre-differentiated versus intact fetal
mesencephalon-derived human neural progenitor cells
in alleviating rat model of Parkinson’s disease
Xuan Wang
a,1, Yanyan Lub
1, Huanqing Zhang
b, Kun Wang
a, Qihua Hea
b,
Yue Wang
a, Xianyu Liu
a, Linsong Li
b,2, Xiaomin Wang
a,c,?
Int. J. Devl Neuroscience 22 (2004) 175-183
Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease
Jose A. RodrÃguez-Gómez
a, Jian-Qiang Lu
b, Iván Velasco
a, Seth Rivera
d, Sami S. Zoghbi
b, Jeih-San Liow
b, John L. Musachio
b, Frederick T. Chin
b, Hiroshi Toyama
b, Jurgen Seidel
c, Michael V. Green
c, Panayotis K. Thanos
d,e, Masanori Ichise
b, Victor W. Pike
b, Robert B. Innis
b, Ron D. G. McKay
a
Stem Cells Vol. 25 No. 4 April 2007, pp. 918-928
Effects of intranigral vs intrastriatal fetal mesencephalic neural grafts on motor behavior disorders in a rat Parkinson model.
B. Goren, N. Kahveci, O. Eyigor, T. Alkan, E. Korfali, K. Ozluk
Surgical Neurology, Volume 64, Pages S33-S41
Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: Brain microdialysis, behavior, and microscopy
Nese Tunçel
a, Erol Sener
b, Cem Cerit
f, Umut Karasu
c, Firdevs Gürer
d, Varol Sahintürk
d, Cengiz Bayçu
d, Dilek Ak
b and Zeynep Filiz
e
Peptides
Volume 26, Issue 5, May 2005, Pages 827-836
Host brain regulation of dopaminergic grafts function: Role of the serotonergic and noradrenergic systems in amphetamine-induced responses
Ana Muñoz, Jannette Rodriguez-Pallares, Maria Jose Guerra, Jose Luis Labandeira-Garcia
Synapse, Volume 47, Issue 1 , Pages 66 - 76
Effects of BDNF and NT-4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo
Ernest Arenas
2, Peter Akerud
2, Vivien Wong
1, Carolyn Boylan
1, Hakan Person
22, Ronald M. Lindsay
1 and C. Anthony Altar
1
European Journal of Neuroscience
Volume 8 Issue 8 Page 1707-1717, August 1996
Intrastriatal administration of erythropoietin protects dopaminergic neurons and improves neurobehavioral outcome in a rat model of Parkinson’s disease
Y.-Q. Xue
a, 1, L.-R. Zhao
a, b, 1, W.-P. Guo
a and W.-M. Duan
a
Neuroscience
Volume 146, Issue 3, 25 May 2007, Pages 1245-1258
The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway
E. Lopez-Martin
1, G. Rozas
1, J. Rodriguez
1, M. J. Guerra
1, J. L. Labandeira-Garcia
1
Experimental Brain Research, Volume 120, Number 2 / May, 1998 Pages 153-163
Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression
J. L. Labandeira-Garcia
1 , G. Rozas
1, E. Lopez-Martin
1, I. Liste
1 and M. J. Guerra
1
Experimental Brain Research, Volume 108, Number 1 / February, 1996 Pages 69-84
Experimental intracerebral hematoma in the rat
Alain Barth
1, Raphael Guzman
2, Robert H. Andres
1, Pasquale Mordasini
1, Laurence Barth
1, Hans R. Widmer
1
Restorative Neurology and Neuroscience Volume 25, Number 1 / 2007 Pages 1-7
Circling behaviour in 6-hydroxydopamine-lesioned rats given pulsed levodopa is reduced more by lesions in the entopeduncular nucleus/substantia nigra pars reticulata than in the subthalamic nucleus
C. R. Honey and H. Shen
Neuroscience Letters Volume 249, Issues 2-3, 19 June 1998, Pages 151-154
The foxa2 Gene Controls the Birth and Spontaneous Degeneration of Dopamine Neurons in Old Age
Kittappa
1, Wendy W. Chang
1, Rajeshwar B. Awatramani
2, Ronald D. G. McKay
1*
PLoS Biology | December 2007 | Volume 5 | Issue 12 | e325
S33138, A PREFERENTIAL DOPAMINE D3 VERSUS D2 RECEPTOR ANTAGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT. II. A NEUROCHEMICAL, ELECTROPHYSIOLOGICAL AND BEHAVIOURAL CHARACTERISATION IN VIVO
Mark J. Millan
1*, Per Svenningson
2, Charles R. Ashby, Jr.
3, Michael Hill
4, Martin Egeland
5, Anne Dekeyne
1, Mauricette Brocco
1, Benjamin Di Cara
1, Francoise Lejeune
1, Nitza Thomasson
6, Carmen Munoz
6, Elisabeth Mocaer
6, Alan Crossman
4, Laetitia Cistarelli
1, Sylvie Girardon
1, Loretta Iob
1, Sylvie Veiga
1, Alain Gobert
1
Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 16, 2007; DOI: 10.1124/jpet.107.132563
Methylparaben protects 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cells and improved behavioral impairments in mouse model of Parkinson's disease
Spandana Rajendra Kopalli, Su-Jin Noh, Sushruta Koppula, Yoo-Hun Suh
NeuroToxicology
Volume 34, January 2013, Pages 25-32
HSP70 and Constitutively Active HSF1 Mediate Protection Against CDCrel-1-mediated Toxicity
Alisha E Jung
1, Helen L Fitzsimons
2, Ross J Bland
2, Matthew J During
1,3 and Deborah Young
1,4
Molecular Therapy (2008) 16 6, 1048-1055
Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats
Alexia E. Pollack
1 and J. Stephen Fink*
Brain Research
Volume 743, Issues 1-2, 16 December 1996, Pages 124-130
Adult human bone marrow stromal spheres express neuronal traits in vitro and in a rat model of Parkinson's disease
Sokreine Suon
a, b, Ming Yang
b and Lorraine Iacovitti
b
Brain Research
Volume 1106, Issue 1, 23 August 2006, Pages 46-51
AAV9-mediated erythropoietin gene delivery into the brain protects nigral dopaminergic neurons in a rat model of Parkinson's disease
Y-Q Xue, B-F Ma, L-R Zhao, J B Tatom, B Li, L-X Jiang, R L Klein and W-M Duan
Gene Therapy advance online publication 3 September 2009; doi: 10.1038/gt.2009.113
Human Amniotic Fluid Stem Cells Do Not Differentiate Into Dopamine Neurons In Vitro or After Transplantation In Vivo
Angela E. Donaldson, Jingli Cai, Ming Yang, Lorraine Iacovitti.
Stem Cells and Development. September 2009, 18(7): 1003-1012
Time course study of fractional anisotropy in the substantia nigra of a parkinsonian rat model induced by 6-OHDA
Wenzhong Zhang, Li Zhang, Limin Liu, Xiaomin Wang
Behavioural Brain Research, Volume 328, 15 June 2017, Pages 130-137